Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune system and bone microenvironment: rationale for targeted cancer therapies.
Gnoni A, Brunetti O, Longo V, Calabrese A, Argentiero AL, Calbi R, Solimando Antonio G, Licchetta A. Gnoni A, et al. Among authors: argentiero al. Oncotarget. 2020 Jan 28;11(4):480-487. doi: 10.18632/oncotarget.27439. eCollection 2020 Jan 28. Oncotarget. 2020. PMID: 32064051 Free PMC article. Review.
Angiogenesis in adenosquamous cancer of pancreas.
Silvestris N, Danza K, Longo V, Brunetti O, Fucci L, Argentiero A, Calabrese A, Cataldo I, Tamma R, Ribatti D, Tommasi S. Silvestris N, et al. Oncotarget. 2017 Sep 27;8(56):95773-95779. doi: 10.18632/oncotarget.21319. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221165 Free PMC article.
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D. Longo V, et al. Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Clin Exp Med. 2018. PMID: 29492715 Review.
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis.
Brunetti O, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Scarpa A, Basile D, Mazzuca F, Graziano G, Argentiero A, Santini D, Reni M, Cascinu S, Silvestris N. Brunetti O, et al. Pancreas. 2018 Jul;47(6):759-771. doi: 10.1097/MPA.0000000000001063. Pancreas. 2018. PMID: 29771769 Free article.
The Italian Rare Pancreatic Exocrine Cancer Initiative.
Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N. Brunetti O, et al. Tumori. 2019 Aug;105(4):353-358. doi: 10.1177/0300891619839461. Epub 2019 Apr 9. Tumori. 2019. PMID: 30967031 Free article.
Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy.
Brunetti O, Badalamenti G, De Summa S, Calabrese A, Argentiero A, Fucci L, Longo V, Galetta D, Perrotti PMS, Pinto R, Petriella D, Danza K, Tommasi S, Leonetti F, Silvestris N. Brunetti O, et al. Cancers (Basel). 2019 May 29;11(6):749. doi: 10.3390/cancers11060749. Cancers (Basel). 2019. PMID: 31146476 Free PMC article.
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper.
Silvestris N, Argentiero A, Cosmai L, Porta C, Gesualdo L, Brunori G, Brunetti O, Rampino T, Secondino S, Rizzo G, Pedrazzoli P. Silvestris N, et al. Crit Rev Oncol Hematol. 2019 Aug;140:39-51. doi: 10.1016/j.critrevonc.2019.05.016. Epub 2019 May 31. Crit Rev Oncol Hematol. 2019. PMID: 31176271 Free article. Review.
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Argentiero A, De Summa S, Di Fonte R, Iacobazzi RM, Porcelli L, Da Vià M, Brunetti O, Azzariti A, Silvestris N, Solimando AG. Argentiero A, et al. Cancers (Basel). 2019 Jul 4;11(7):942. doi: 10.3390/cancers11070942. Cancers (Basel). 2019. PMID: 31277479 Free PMC article.
62 results